Long-Acting Insulin: Slow Release of Insulin From a Biodegradable Matrix Implanted in Diabetic Rats

Diabetes - United States
doi 10.2337/diab.32.5.478
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Diabetes Association

Related search

Long Acting Insulin Glargine Overdose, a Surprising Long Lifetime

Toxicology Communications
2019English

Pancreatic Islet Overproduction of H2S and Suppressed Insulin Release in Zucker Diabetic Rats

Laboratory Investigation
Forensic MedicinePathologyCell BiologyMolecular Biology
2008English

Systematic Review and Economic Evaluation of a Long-Acting Insulin Analogue, Insulin Glargine

Health Technology Assessment
MedicineHealth Policy
2004English

Effect of a Phospho-Oligosaccharidic Putative Insulin Messenger on Insulin Release in Rats

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
1989English

Long-Term Continuous Intraperitoneal Insulin Infusion With an Implanted Remote-Controlled Insulin Infusion Device

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
1981English

Prevention of Diabetic Glomerulopathy in Streptozotocin Diabetic Rats by Insulin Treatment

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
1979English

Design of the Novel Protraction Mechanism of Insulin Degludec, an Ultra-Long-Acting Basal Insulin

Pharmaceutical Research
Organic ChemistryBiotechnologyMolecular MedicinePharmacologyPharmaceutical Science
2012English

Insulin Toujeo® — A Novel Basal Long-Acting Insulin Formulation. Part 2. Clinical Efficacy and Safety

INTERNATIONAL JOURNAL OF ENDOCRINOLOGY
2016English

Budget Impact of Long-Acting Insulin Analogues: The Case in Brazil

PLoS ONE
Multidisciplinary
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy